As of 1 July 2019, the Technical Review Panel (TRP) has completed its reviews of funding requests for the 2017-2019 allocations and has issued recommendations covering all of the funds available for country allocation ($10.3 billion); all of the matching funds that were subject to TRP review ($313 million); and all of the funds earmarked for multi-country grants ($260 million).
You are here
Global Fund Board gives the Secretariat the green light to prepare proposals for investing in non-eligible countries in crisis (e.g. Venezuela)
Catastrophe in Venezuela imperils the achievement of the Global Fund Strategy (2017-2022), says new report
Venezuela is in the middle of an unprecedented, state-made, complex humanitarian emergency. The public health crisis, which is just a symptom of the larger unraveling that is unfolding, has reached extreme levels. Essentials like soap and gloves have vanished from hospital floors. Life-saving medications are sometimes only available on the black market and cost half a month’s wages.
It might surprise you to learn that challenging operating environments account for a third of the global disease burden for HIV, TB, and malaria, and a third of Global Fund investments. (For malaria alone, the proportion is 50%.) This makes COEs particularly critical to the Fund’s mission and objectives.
At its meeting in Abidjan on 26-27 April, the Board adopted a policy on COEs.
The Secretariat has provided an update on Special Initiatives to the Strategy, Investment and Impact Committee and the Financial and Operational Performance Committee. The update has not been made public, but Aidspan has received permission to report on its contents.